| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000027586.64231.1B |
| P698 | PubMed publication ID | 12208805 |
| P2093 | author name string | Pin-Lan Li | |
| Ai-Ping Zou | |||
| Ya-Fei Chen | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1275-1281 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function | |
| P478 | volume | 106 |
| Q35474438 | Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice |
| Q34425178 | Acid sphingomyelinase gene knockout ameliorates hyperhomocysteinemic glomerular injury in mice lacking cystathionine-β-synthase |
| Q40112621 | Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease. |
| Q54406166 | DNA methylation status of the methylenetetrahydrofolate reductase gene promoter in peripheral blood of end-stage renal disease patients. |
| Q35600418 | Does homocysteine cause hypertension? |
| Q46738131 | Effects of moderate hyperhomocysteinaemia induced by 4 weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats |
| Q35821693 | Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia |
| Q37117183 | High homocysteine levels prevent via H2 S the CoCl2 -induced alteration of lymphocyte viability |
| Q37700613 | Homocysteine metabolism in children with idiopathic nephrotic syndrome |
| Q46663117 | Hyperhomocysteinaemia induced by dietary folate restriction causes kidney oxidative stress in rats |
| Q36273319 | Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients |
| Q45219986 | Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors |
| Q44986757 | Increased homocysteine and decreased adenosine formation in Alzheimer's disease |
| Q83317779 | Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats |
| Q36894381 | Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion |
| Q40356802 | Maternal and Fetal Folate, Vitamin B12, and Homocysteine Concentrations and Childhood Kidney Outcomes |
| Q33646673 | Mechanisms of homocysteine-induced glomerular injury and sclerosis |
| Q46976062 | N-acetylcysteine is a highly available precursor for cysteine in the neonatal piglet receiving parenteral nutrition. |
| Q46765278 | Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study |
| Q46035664 | Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study. |
| Q46784085 | Positive association between plasma homocysteine level and chronic kidney disease |
| Q33729668 | Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene |
| Q36844159 | Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury |
| Q36273296 | Reduced adenosine receptor stimulation as a pathogenic factor in hyperhomocysteinemia. |
| Q34546376 | S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism |
| Q37246161 | The worldwide challenge of the dementias: a role for B vitamins and homocysteine? |
| Q44463826 | Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney |
| Q35211309 | Vasoconstrictor and vasodilator effects of adenosine in the kidney. |
Search more.